CLINDAMYCIN INJECTION

The contract is a delivery order under the IDIQ contract SPE2DX25D9822 issued by the Defense Logistics Agency through its Medical Supply Chain FSB, awarding a single line item of CLINDAMYCIN INJECTION (NSN 6505011875540) to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) at a total price of $69.95. The delivery is scheduled for July 16, 2026, with FOB Destination terms placing transportation cost and risk on the contractor until receipt at Electric Boat Corporation in North Stonington, Connecticut. The contract is structured as a commercial item acquisition under FAR 52.212-4 and 52.212-5, indicating a firm-fixed-price arrangement with no options or varied quantities. The awardee is certified as a Women-Owned Small Business and Economically Disadvantaged Women-Owned Small Business under NAICS code 325412, with a size standard of 1,300 employees, and the contract is subject to the Defense Priorities and Allocations System. Packaging requires shipment via fastest traceable means with parcel post prohibited, and labeling must include the part number NDC00009-0902-18, CAGE code 86491, CLIN 0001, RDD 999, and DIC A4A, though specific MIL-STD labeling or preservation requirements are not mandated. Inspection and acceptance occur at the destination by the Government, with invoice submission directed to the Defense Finance and Accounting Service in Columbus, Ohio. The contracting officer is Lorinda Ferraiolo and the functional COTR is Catherine Gilbert, with no formal COR designated. The underlying IDIQ contract has a $20,000,000 ceiling, but this delivery order represents only the single-line-item purchase. Standard Form 1449 is used for documentation, supported by one attachment titled “PPVG GEN V SPE2DX-25-D-9822 FLEET MILSTRIP BACKUP BASE ADMIN.pdf,” and invoicing is expected through the WAWF system by inference, though not explicitly confirmed. No special contract requirements, security clearances, key personnel provisions, or OCI clauses are identified, and while payment terms are Fast Pay Net 15, no specific accounting or appropriation data is